Cantel Medical Corporation
CMD
CMD was delisted on the 1st of June, 2021.
231 hedge funds and large institutions have $3.42B invested in Cantel Medical Corporation in 2017 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 69 increasing their positions, 85 reducing their positions, and 16 closing their positions.
131% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 16
23% more capital invested
Capital invested by funds: $2.77B → $3.42B (+$645M)
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
8% more funds holding
Funds holding: 214 → 231 (+17)
19% less repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 85
69% less call options, than puts
Call options by funds: $3.42M | Put options by funds: $10.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$50.5M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$42.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$29.1M |
| 4 |
Goldman Sachs
New York
|
+$12.9M |
| 5 |
Cerity Partners
New York
|
+$11.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$34.9M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$22.3M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$13.6M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$10M |
| 5 |
Janus Henderson Group
London,
|
-$8.21M |
CMD Hedge Fund Activity: Q3 2017 in Review
231 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q3 2017, worth a combined $3.42B — up 23% from $2.77B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new CMD positions and 16 closed out — a net gain of 21 holders — while 69 added to existing stakes and 85 trimmed.
The largest buyer was Pictet Asset Management (UK), adding an estimated $50.5M. The largest seller was Brown Capital Management, cutting an estimated $34.9M.
- 231 institutional investors held Cantel Medical Corporation (CMD) as of Q3 2017, up from 214 in Q2 2017.
- Funds reported $3.42B of Cantel Medical Corporation stock for Q3 2017, up 23% quarter-over-quarter.
- 37 funds opened new Cantel Medical Corporation positions in Q3 2017 and 16 closed out, a net change of +21 holders.
- The largest Cantel Medical Corporation buyer in Q3 2017 was Pictet Asset Management (UK), an estimated $50.5M added.
- The largest Cantel Medical Corporation seller in Q3 2017 was Brown Capital Management, an estimated $34.9M sold.
Based on aggregated 13F filings for Q3 2017.